Journal of Traditional Chinese Medicine >
Efficacy of Heshouwu (Radix Polygoni Multiflori) on gut mircobiota in mice with autoimmune encephalomyelitis
Received date: 2022-10-22
Accepted date: 2023-03-04
Online published: 2023-07-03
Supported by
National Natural Science Foundation of China: Role and Mechanism of Akkermansia-Mediated Activation of Microglia NLRP3 Inflammasome in Multiple Sclerosis(82101419);Jiangxi Provincial Natural Science Foundation: the Role and Mechanism of p38 MAPK Signaling Pathway Induced by Intestinal Flora Change in EAE Mice(20212BAB216024);Jiangxi Science and Technology Project of Chinese Medicine: Study on the Role and Mechanism of CGAS-STING Signaling Pathway in Microglia Mediated by Rhodiola Sachalinensis in Multiple Sclerosis(2021B660);Jiangxi Science and Technology Project of Chinese Medicine: Study on the Role and Mechanism of CGAS-STING Signaling Pathway in Microglia Mediated by Rhodiola Sachalinensis in Multiple Sclerosis(2022B1007);Jiangxi Science and Technology Program of Health Commission: the Role and Mechanism of Intestinal Flora Changes in Mediating the Activation of NLRP3 Inflammasome in Microglia in Multiple Sclerosis(202210392);Science and Technology Research Project of Jiangxi Education: Study on the Role and Mechanism of p38 MAPK Signaling Pathway Induced by Intestinal Flora Changes in EAE Mice(GJJ200215);Scientific Research and Development Project of the First Affiliated Hospital of Nanchang University: Effects of Exercise Training on Intestinal Flora of Multiple Sclerosis Model Rats and Its Mechanism(YFYPY202021)
OBJECTIVE: To learn the mechanisms between gut microbiome and the autoimmunity benefits on Traditional Chinese Medicine (TCM) in central nervous system (CNS), we investigated the neuro-protection effects and gut mircobiota changes of Heshouwu (Radix Polygoni Multiflori) on experimental autoimmune encepha-lomyelitis (EAE), an animal model of multiple sclerosis (MS).
METHODS: Mice were randomly divided into four groups: EAE mice (control phosphate-buffered saline group), 50 mg·kg-1·d-1 Heshouwu (Radix Polygoni Multiflori)-treated EAE mice, 100 mg·kg-1·d-1 Heshouwu (Radix Polygoni Multiflori)-treated EAE mice, and 200 mg·kg-1·d-1 Heshouwu (Radix Polygoni Multiflori)-treated EAE mice. The spinal cords were stained with hematoxylin and eosin (HE) and luxol fast blue for evaluating inflammatory infiltration and demyelination. The percentages of granulocyte macrophage-colony stimulating factor (GM-CSF)+CD4+, interleukin 17 (IL-17)+CD4+, Foxp3 CD4+, and interferon-γ (IFN-γ)+CD4+ T cells in the inguinal lymph nodes (LNs) and brain were determined by flow cytometry analysis. 16S rRNA gene sequencing was employed to analyze the changes in gut microbiota.
RESULTS: We found that Heshouwu (Radix Polygoni Multiflori) alleviated the disease severity and neuropathology of EAE as evaluated by clinical and histopathologyical scores. Heshouwu (Radix Polygoni Multiflori) increased the diversity and abundance of the gut microbiota, and decreased Firmicutes/Bacteroidetes ratio (F/B ratio). Heshouwu (Radix Polygoni Multiflori) also decreased the concentrations of IL-10, and IL-21 and increase the levels of GM-CSF, IL-17A, IL-17F and IL-22 in serum of EAE mice. Moreover, Heshouwu (Radix Polygoni Multiflori) modulated the T cell responses by inhibiting Th17 cells and restoring Treg cells in the small intestine lymphoid tissues and inguinal lymph nodes. Microbiota-depleted mice receiving Heshouwu (Radix Polygoni Multiflori)-treated fecal microbiota trans-plantation had lower disease severity, neuropathology scores and alleviation of Th17/Treg imbalance compared to ad libitum group.
CONCLUSIONS: Our findings suggested that the vital neuro-protection role of Heshouwu (Radix Polygoni Multiflori) (TCM) in immunomodulation effects partly by regulations of gut microbiome.
Jun ZHOU , Junhua WANG , Xiaobing LI , Chenyi WAN , Fangjun LI , Yanni Lü , Hao CHEN , Meiying SUN . Efficacy of Heshouwu (Radix Polygoni Multiflori) on gut mircobiota in mice with autoimmune encephalomyelitis[J]. Journal of Traditional Chinese Medicine, 2023 , 43(4) : 676 -685 . DOI: 10.19852/j.cnki.jtcm.2023.04.001
| 1. | Correale J, Gaitan MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 2017; 140: 527-46. |
| 2. | Olek MJ. Multiple sclerosis. Ann Intern Med 2021; 174: Itc81-96. |
| 3. | Lecuyer E, Rakotobe S, Lengline-Garnier H, et al. Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses. Immunity 2014; 40: 608-20. |
| 4. | Yang Y, Torchinsky MB, Gobert M, et al. Focused specificity of intestinal T(H)17 cells towards commensal bacterial antigens. Nature 2014; 510: 152-6. |
| 5. | Chen H, Ma X, Si L, et al. Traditional Chinese Medicine in multiple sclerosis: theory and practice. Curr Pharmacol Rep 2018; 4: 436-46. |
| 6. | Peng Y, Zhang S, Liu Z, et al. Gut microbiota and Chinese medicine syndrome: altered fecal microbiotas in spleen (Pi)-deficient patients. J Tradit Chin Med 2020; 40: 137-43. |
| 7. | Lyu M, Wang YF, Fan GW, Wang XY, Xu SY, Zhu Y. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Front Microbiol 2017; 8: 2146. |
| 8. | Wu J, Wei Z, Cheng P, et al. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis. Theranostics 2020; 10: 10665-79. |
| 9. | Lin L, Ni B, Lin H, et al. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol 2015; 159: 158-83. |
| 10. | Bounda GA, Feng YU. Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds. Pharmacognosy Res 2015; 7: 225-36. |
| 11. | Sun Y, Mei L, Seon Y, et al. Novel compound from Polygonum multiflorum inhibits inflammatory response in LPS-stimulated microglia by upregulating AMPK/Nrf2 pathways. Neurochem Int 2016; 100: 21-9. |
| 12. | Zhou X, Yang Q, Xie Y, et al. Tetrahydroxystilbene glucoside extends mouse life span via upregulating neural klotho and downregulating neural insulin or insulin-like growth factor 1. Neurobiol Aging 2015; 36: 1462-70. |
| 13. | Chen H, Ma X, Liu Y, et al. Gut microbiota interventions with clostridium butyricum and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice. Front Immunol 2019; 10: 1662. |
| 14. | Chen H, Shen L, Liu Y, et al. Strength exercise confers protection in central nervous system autoimmunity by altering the gut microbiota. Front Immunol 2021; 12: 628629. |
| 15. | Rao T, Liu YT, Zeng XC, Li CP, Ouyang DS. The hepatotoxicity of Polygonum multiflorum: the emerging role of the immune-mediated liver injury. Acta Pharmacol Sin 2021; 42: 27-35. |
| 16. | O'Neill EJ, Day MJ, Wraith DC. IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE. J Neuroimmunol 2006; 178: 1-8. |
| 17. | Zeinali H, Baluchnejadmojarad T, Fallah S, Sedighi M, Moradi N, Roghani M. S-allyl cysteine improves clinical and neuropathological features of experimental autoimmune encephalomyelitis in C57BL/6 mice. Biomed Pharmacother 2018; 97: 557-63. |
| 18. | Chen H, Chen Z, Shen L, et al. Fecal microbiota transplantation from patients with autoimmune encephalitis modulates Th 17 response and relevant behaviors in mice. Cell Death Discov 2020; 6: 75. |
| 19. | Bellemore SM, Nikoopour E, Schwartz JA, Krougly O, Lee-Chan E, Singh B. Preventative role of interleukin-17 producing regulatory T helper type 17 (T(reg)17) cells in type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 2015; 182: 261-9. |
| 20. | McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat Immunol 2007; 8: 1390-7. |
| 21. | Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009; 9: 393-407. |
| 22. | Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31: 677-89. |
| 23. | Jarrell JT, Gao L, Cohen DS, Huang X. Network medicine for alzheimer's disease and Traditional Chinese Medicine. Molecules (Basel, Switzerland) 2018; 23: 1143. |
| 24. | Wang ZY, Liu J, Zhu Z, et al. Traditional Chinese Medicine compounds regulate autophagy for treating neurodegenerative disease: a mechanism review. Biomed Pharmacother 2021; 133: 110968. |
| 25. | Qi MZ, Su XH, Lin N, Kong XY. Effect of neutrophil extracellular traps on ischemic stroke and intervention of Traditional Chinese Medicine. Zhong Guo Zhong Yao Za Zhi 2021; 46: 1-5. |
| 26. | Zhang Y, Lou Y, Wang J, Yu C, Shen W. Research status and molecular mechanism of the Traditional Chinese Medicine and antitumor therapy combined strategy based on tumor microenvironment. Front Immunol 2020; 11: 609705. |
| 27. | Lin X, Liu Y, Ma L, et al. Amelioration of experimental autoimmune encephalomyelitis by Rhodiola rosea, a natural adaptogen. Biomed Pharmacother 2020; 125: 109960. |
| 28. | Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol 2017; 17: 219-32. |
| 29. | Chang CJ, Lin CS, Lu CC, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 2015; 6: 7489. |
| 30. | Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-3. |
| 31. | Julia V, Macia L, Dombrowicz D. The impact of diet on asthma and allergic diseases. Nat Rev Immunol 2015; 15: 308-22. |
| 32. | Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61: 364-71. |
| 33. | Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, NY) 2013; 341: 569-73. |
| 34. | Anhê FF, Roy D, Pilon G, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015; 64: 872-83. |
| 35. | Logsdon AF, Erickson MA, Rhea EM, Salameh TS, Banks WA. Gut reactions: how the blood-brain barrier connects the microbiome and the brain. Exp Biol Med (Maywood, NJ) 2018; 243: 159-65. |
| 36. | Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol 2015; 15: 545-58. |
| 37. | Uyttenhove C, Gaignage M, Donckers D, et al. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis. Eur J Immunol 2018; 48: 1883-91. |
| 38. | Vendrik KEW, Ooijevaar RE, de Jong PRC, et al. Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol 2020; 10: 98. |
| 39. | Kong G, Ellul S, Narayana VK, et al. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease. Neurobiol Dis 2021; 148: 105199. |
/
| 〈 |
|
〉 |